In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor-Reference-Cited by-同舟云学术

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

Published:2008-06 Issue:1-3 Volume:587 Page:141-146
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Aluisio Leah,Lord Brian,Barbier Ann J.,Fraser Ian C.,Wilson Sandy J.,Boggs Jamin,Dvorak Lisa K.,Letavic Michael A.,Maryanoff Bruce E.,Carruthers Nicholas I.,Bonaventure Pascal,Lovenberg Timothy W.

Publisher

Elsevier BV

Subject

Pharmacology

Reference23 articles.

1. Major depression in 1998: are we providing optimal therapy?;Angst;J. Clin. Psychiatry,1999

2. Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor;Barbier;Eur. J. Pharmacol.,2007

3. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents;Bonaventure;J. Pharmacol. Exp. Ther.,2007

4. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice;Cryan;Neurosci. Biobehav. Rev.,2005

5. The role of dopamine in the mechanism of action of antidepressant drugs;D’Aquila;Eur. J. Pharmacol.,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New approaches to the synthesis of benzo[h]pyrroloisoquinoline derivatives;Tetrahedron Letters;2019-11

2. Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges;Journal of Medicinal Chemistry;2017-07-21

3. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders;Drug Discovery Today;2016-12

4. Multiple Targeting Approaches on Histamine H3 Receptor Antagonists;Frontiers in Neuroscience;2016-05-30

5. Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?;Future Medicinal Chemistry;2015-11